Furthermore, the use of gastric cancer exosomal THBS1 to enhance production of IFN-γ, TNF-α, perforin, and granzyme B in vitro, to ultimately elevate the killing of gastric cancer cells by Vδ2 T cells in vivo, has yielded successful preclinical trials [195, 196]. This evidence concerns the gene IFNG and gastric cancer.